Pfizer Inc. (ETR:PFE)
23.12
+0.02 (0.06%)
Mar 31, 2025, 4:35 PM CET
Pfizer Revenue
In the year 2024, Pfizer had annual revenue of $63.63B USD with 6.84% growth. Pfizer had revenue of $17.76B in the quarter ending December 31, 2024, with 21.92% growth.
Revenue
$63.63B
Revenue Growth
+6.84%
P/S Ratio
n/a
Revenue / Employee
$785.52K
Employees
81,000
Market Cap
132.00B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Bayer Aktiengesellschaft | 46.61B |
Sartorius Aktiengesellschaft | 3.38B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
Pfizer News
- 46 minutes ago - Vaccine stocks fall after key FDA official resigns in protest of RFK Jr. - CNBC
- 3 hours ago - Biotech stocks tumble on reports FDA's top vaccine regulator to leave - Reuters
- 1 day ago - Abbott Labs and Pfizer Lead the Cardiovascular Innovation Market - GuruFocus
- 1 day ago - Pfizer (PFE) and Vaccine Makers Face Challenges After FDA Resignation - GuruFocus
- 2 days ago - Pfizer and other pandemic favorites in focus as FDA’s top vaccine regulator resigns - Seeking Alpha
- 2 days ago - What Does the Market Think About Pfizer? - Benzinga
- 2 days ago - Pfizer: Shares Stabilize At $25 As Institutions Begin To Load Up (Rating Upgrade) - Seeking Alpha
- 3 days ago - 6 Ultra SWANs Potentially Set To Soar In 2025 - Seeking Alpha